Pub Date : 2025-01-01Epub Date: 2025-01-02DOI: 10.1080/09553002.2024.2445582
Serhat Aras, Seyma Ozkanli, Engin Sumer, Tugba Kul Koprulu, Mustafa Efendioglu
Purpose: The aim of this study was to investigate the radiobiological effects underlying the inhibition of breast cancer (BCa) following radiotherapy in nude mice models, and to evaluate the impact of changes in immunohistochemical parameters induced by FF and FFF beams.
Materials and methods: The study included thirty-six adult nude mouse models, which were randomly assigned to five groups: control (G1), breast cancer (BCa) (G2), FF-400 MU/min (G3), FFF-1100 MU/min (G4), and FFF-1800 MU/min (G5). The control group received neither radiation nor treatment, while the BCa group had a cancer model without radiation. The BCa models were subjected to a single dose of 20 Gy of radiotherapy at varying dose rates. Twenty days after the implantation of the MCF-7 cancer cell line, the nude mice were irradiated and sacrificed 48 h later for ER, PR, HER-2, Ki-67, CD-133, Caspase-3, APAF-1, NOS-2 and NOS-3 IHC analysis.
Results: A statistically significant decrease in IHC staining values for ER, Ki-67 and NOS-2 was observed in the FF-400 MU/min, FFF-1100 MU/min and FFF-1800 MU/min groups due to radiotherapy compared to the BCa group. The FFF beams demonstrated superior efficacy in the treatment of BCa. The significant differences in Caspase-3 and APAF-1 levels were found between BCa and control groups, while CD-133, NOS-3, HER-2, and PR staining showed no differences between groups.
Conclusions: It was concluded that FFF beam was more effective than FF beam for BCa, especially on ER, Ki-67 and NOS-2 IHC parameters.
{"title":"Examination of immunohistochemical of the effects of flattened and unflattened radiotherapy beams in nude mice breast cancer xenografts.","authors":"Serhat Aras, Seyma Ozkanli, Engin Sumer, Tugba Kul Koprulu, Mustafa Efendioglu","doi":"10.1080/09553002.2024.2445582","DOIUrl":"10.1080/09553002.2024.2445582","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study was to investigate the radiobiological effects underlying the inhibition of breast cancer (BCa) following radiotherapy in nude mice models, and to evaluate the impact of changes in immunohistochemical parameters induced by FF and FFF beams.</p><p><strong>Materials and methods: </strong>The study included thirty-six adult nude mouse models, which were randomly assigned to five groups: control (G1), breast cancer (BCa) (G2), FF-400 MU/min (G3), FFF-1100 MU/min (G4), and FFF-1800 MU/min (G5). The control group received neither radiation nor treatment, while the BCa group had a cancer model without radiation. The BCa models were subjected to a single dose of 20 Gy of radiotherapy at varying dose rates. Twenty days after the implantation of the MCF-7 cancer cell line, the nude mice were irradiated and sacrificed 48 h later for ER, PR, HER-2, Ki-67, CD-133, Caspase-3, APAF-1, NOS-2 and NOS-3 IHC analysis.</p><p><strong>Results: </strong>A statistically significant decrease in IHC staining values for ER, Ki-67 and NOS-2 was observed in the FF-400 MU/min, FFF-1100 MU/min and FFF-1800 MU/min groups due to radiotherapy compared to the BCa group. The FFF beams demonstrated superior efficacy in the treatment of BCa. The significant differences in Caspase-3 and APAF-1 levels were found between BCa and control groups, while CD-133, NOS-3, HER-2, and PR staining showed no differences between groups.</p><p><strong>Conclusions: </strong>It was concluded that FFF beam was more effective than FF beam for BCa, especially on ER, Ki-67 and NOS-2 IHC parameters.</p>","PeriodicalId":94057,"journal":{"name":"International journal of radiation biology","volume":" ","pages":"264-273"},"PeriodicalIF":2.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: The effects of ionizing radiation on living organisms are mainly known as the generation of reactive oxygen species (ROS), apoptosis, and DNA damage. Small GTPases (RhoA, Rac1, Cdc42) are known to have roles in the regulation of oxidative stress and apoptosis. The aim of this study was to investigate the role of the RhoA molecule in testicular tissue damage due to oxidative stress and apoptosis induced by ionizing radiation.
Material and method: In this study, testicular tissues and blood samples obtained from our previous study were examined. In that study, rats were exposed to ionizing radiation at three different doses (0.02 Gy, 0.1 Gy, 5 Gy). Then tissue and blood samples were taken at three different times (2 hours, 24 hours, and 7 days) after irradiation. Immunohistochemical staining was performed to evaluate RhoA and cleaved caspase-3 expressions, while RhoA activity was assessed by G-LISA assay in testicular tissues. Serum malondialdehyde (MDA) levels and superoxide dismutase (SOD) activity were analyzed to evaluate oxidative stress.
Results: The expression and activation of RhoA demonstrated a time-dependent increase across all levels of radiation doses. Similarly, the expression of cleaved caspase-3 also exhibited a time-dependent increase, consistent with the effects of radiation-induced damage observed in all experimental groups. After exposure to radiation, serum levels of MDA increased, while the activity of SOD decreased.
Conclusion: Our findings suggest that RhoA may contribute to radiation-induced testicular tissue damage by increasing oxidative stress and apoptosis.
{"title":"Ionizing radiation-induced testicular oxidative stress and apoptosis: the role of small GTPase RhoA.","authors":"Yasar Aysun Manisalıgil, Ayşegül Yurt, Cemre Ural Özkan, Serap Cilaker Mıcılı, Gizem Şişman, Zahide Çavdar, Mukaddes Gümüştekin","doi":"10.1080/09553002.2025.2552248","DOIUrl":"10.1080/09553002.2025.2552248","url":null,"abstract":"<p><strong>Purpose: </strong>The effects of ionizing radiation on living organisms are mainly known as the generation of reactive oxygen species (ROS), apoptosis, and DNA damage. Small GTPases (RhoA, Rac1, Cdc42) are known to have roles in the regulation of oxidative stress and apoptosis. The aim of this study was to investigate the role of the RhoA molecule in testicular tissue damage due to oxidative stress and apoptosis induced by ionizing radiation.</p><p><strong>Material and method: </strong>In this study, testicular tissues and blood samples obtained from our previous study were examined. In that study, rats were exposed to ionizing radiation at three different doses (0.02 Gy, 0.1 Gy, 5 Gy). Then tissue and blood samples were taken at three different times (2 hours, 24 hours, and 7 days) after irradiation. Immunohistochemical staining was performed to evaluate RhoA and cleaved caspase-3 expressions, while RhoA activity was assessed by G-LISA assay in testicular tissues. Serum malondialdehyde (MDA) levels and superoxide dismutase (SOD) activity were analyzed to evaluate oxidative stress.</p><p><strong>Results: </strong>The expression and activation of RhoA demonstrated a time-dependent increase across all levels of radiation doses. Similarly, the expression of cleaved caspase-3 also exhibited a time-dependent increase, consistent with the effects of radiation-induced damage observed in all experimental groups. After exposure to radiation, serum levels of MDA increased, while the activity of SOD decreased.</p><p><strong>Conclusion: </strong>Our findings suggest that RhoA may contribute to radiation-induced testicular tissue damage by increasing oxidative stress and apoptosis.</p>","PeriodicalId":94057,"journal":{"name":"International journal of radiation biology","volume":" ","pages":"1135-1141"},"PeriodicalIF":2.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144984099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-09-23DOI: 10.1080/09553002.2025.2561808
Preetha Rajaraman, Andreas Klaus Breitbarth, Mai Utada, Syed Asrafuzzaman, Amy Berrington de Gonzalez, Nobuyuki Hamada, Mark P Little
Purpose: Growing evidence from the Japanese atomic bomb survivors, and occupationally and medically exposed groups indicates that ionizing radiation could increase the risk of various diseases of the circulatory system (DCS), even at low levels of exposure. As radiation protection systems increasingly consider the possibility of individualized radiation protection, better understanding is needed of the factors that may impact radiation-related risk, whether intrinsic (such as age, sex or genetics), or extrinsic (such as smoking). Here, we comprehensively review potential effect modification of radiation exposure and the risk of DCS in medical, occupational and environmental settings.Conclusion: Several studies indicate potential effect modification, usually detrimental, with use of anthracycline in medical settings. There was some indication that younger age at exposure increased risk for various DCS outcomes, but this was less consistent across studies and settings. Interpretation of the data is complicated by considerations of statistical power, differences in specific disease outcomes, and narrow ranges of exposure and/or potential modifiers within studies. Future studies with well-defined exposure over a wide range of ages, along with biological samples, are required to better inform the nature of these interactions.
{"title":"Factors governing individual response to ionizing radiation and risk of diseases of the circulatory system: human epidemiological studies.","authors":"Preetha Rajaraman, Andreas Klaus Breitbarth, Mai Utada, Syed Asrafuzzaman, Amy Berrington de Gonzalez, Nobuyuki Hamada, Mark P Little","doi":"10.1080/09553002.2025.2561808","DOIUrl":"10.1080/09553002.2025.2561808","url":null,"abstract":"<p><p><b>Purpose</b>: Growing evidence from the Japanese atomic bomb survivors, and occupationally and medically exposed groups indicates that ionizing radiation could increase the risk of various diseases of the circulatory system (DCS), even at low levels of exposure. As radiation protection systems increasingly consider the possibility of individualized radiation protection, better understanding is needed of the factors that may impact radiation-related risk, whether intrinsic (such as age, sex or genetics), or extrinsic (such as smoking). Here, we comprehensively review potential effect modification of radiation exposure and the risk of DCS in medical, occupational and environmental settings.<b>Conclusion:</b> Several studies indicate potential effect modification, usually detrimental, with use of anthracycline in medical settings. There was some indication that younger age at exposure increased risk for various DCS outcomes, but this was less consistent across studies and settings. Interpretation of the data is complicated by considerations of statistical power, differences in specific disease outcomes, and narrow ranges of exposure and/or potential modifiers within studies. Future studies with well-defined exposure over a wide range of ages, along with biological samples, are required to better inform the nature of these interactions.</p>","PeriodicalId":94057,"journal":{"name":"International journal of radiation biology","volume":" ","pages":"1085-1097"},"PeriodicalIF":2.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145133191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: MicroRNAs (miRNAs) are a group of small non-coding RNAs that substantially participate in regulating gene expression. Their participation in cancer development encompasses various critical pathways, spanning from cell transformation to the progression of tumor cells, metastasis, and even resistance to treatment. This study aimed to assess the impact of miR-206 on radiosensitivity in breast cancer (BC) cells, SIRT1 activity, and p53 acetylation.
Method: miR-206 mimic or inhibitor was transfected into BC cell lines and exposed to X-ray radiation. MTT and colony-forming assays were used to estimate cell viability, and apoptosis was inspected using flow cytometry. SIRT1 enzymatic activity was assessed by a fluorescence method. The protein levels of p53 and its acetylation status were evaluated using western blotting. miR-206 levels were assessed in the breast tumor, marginal, and normal control tissue.
Results: The expression of miR-206 was significantly reduced in BC cell lines and tumor tissue compared to normal tissue. miR-206 reduced cell viability and induced apoptosis, and could enhance the suppressive effects of irradiation on cell viability, colony formation, and its ability to induce apoptosis. miR-206 effectively suppressed SIRT1 activity in BC cells. Moreover, miR-206 significantly increased the levels of p53 and its acetylated form.
Conclusion: The upregulation of miR-206 enhanced the efficacy of radiotherapy by promoting apoptosis and reducing cell survival. It also resulted in elevated levels of p53 and its acetylation. Therefore, miR-206 may be considered a promising candidate for radiosensitizing BC cells.
{"title":"Upregulation of miR-206 attenuates breast cancer cell survival and increases their radiosensitivity.","authors":"Parvaneh Seiri, Parichehr Mehrafshar, Mitra Nourbakhsh, Zahra Hesari, Zohreh Abdolvahabi, Mohammad Soukhtanloo, Pegah Golpour, Zeynab Yousefi, Sahar Yarahmadi, Samira Ezzati Mobaser, Meysam Abolmaali, Zahra Abbasian, Hannaneh Zarrinnahad, Nazanin Hosseinkhan, Seied Rabi Mahdavi","doi":"10.1080/09553002.2025.2540359","DOIUrl":"10.1080/09553002.2025.2540359","url":null,"abstract":"<p><strong>Background: </strong>MicroRNAs (miRNAs) are a group of small non-coding RNAs that substantially participate in regulating gene expression. Their participation in cancer development encompasses various critical pathways, spanning from cell transformation to the progression of tumor cells, metastasis, and even resistance to treatment. This study aimed to assess the impact of miR-206 on radiosensitivity in breast cancer (BC) cells, SIRT1 activity, and p53 acetylation.</p><p><strong>Method: </strong>miR-206 mimic or inhibitor was transfected into BC cell lines and exposed to X-ray radiation. MTT and colony-forming assays were used to estimate cell viability, and apoptosis was inspected using flow cytometry. SIRT1 enzymatic activity was assessed by a fluorescence method. The protein levels of p53 and its acetylation status were evaluated using western blotting. miR-206 levels were assessed in the breast tumor, marginal, and normal control tissue.</p><p><strong>Results: </strong>The expression of miR-206 was significantly reduced in BC cell lines and tumor tissue compared to normal tissue. miR-206 reduced cell viability and induced apoptosis, and could enhance the suppressive effects of irradiation on cell viability, colony formation, and its ability to induce apoptosis. miR-206 effectively suppressed SIRT1 activity in BC cells. Moreover, miR-206 significantly increased the levels of p53 and its acetylated form.</p><p><strong>Conclusion: </strong>The upregulation of miR-206 enhanced the efficacy of radiotherapy by promoting apoptosis and reducing cell survival. It also resulted in elevated levels of p53 and its acetylation. Therefore, miR-206 may be considered a promising candidate for radiosensitizing BC cells.</p>","PeriodicalId":94057,"journal":{"name":"International journal of radiation biology","volume":" ","pages":"1105-1116"},"PeriodicalIF":2.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145202641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-09-16DOI: 10.1080/09553002.2025.2560856
Gürsel Çetinkaya, Mustafa Kayan, Mustafa Saygın, Ayşe Say, Gülşah Çıralı
Background: It is important to reduce the exposure to ionizing radiation, which is increasing due to medical diagnosis and treatments, and to determine the damage in the organism and the biological response to it. We aimed to investigate the radiological and biological effects of dose reduction in computed tomography pulmonary angiography (CTPA), which is increasingly used.
Methods: 123 patients who underwent CTPA with suspicion of pulmonary thromboembolism were divided into three groups and imaging was performed at three different kilovolt (kV) values (80, 100 and 120). Diagnostic quality, radiation exposure parameters (effective dose and dose length product [DLP]), oxidative stress parameters such as total oxidant status (TOS), malondialdehyde (MDA), oxidative stress index (OSI) and total antioxidant status (TAS) in pre- and post-scanning blood samples were evaluated. DNA was determined by comet assay.
Results: No significant difference was found in terms of diagnostic quality between the three groups (p > .005). Radiation exposure parameters increased statistically significantly in line with the kV values (p < .05). The smallest increase in DNA damage after scan was detected in the group with the 80 kV(p = .001). The increase in TOS, MDA and OSI values after imaging in all three groups was not statistically significant (p > .005). The decrease in TAS values was statistically significant only in groups II and III (p < .005).
Conclusion: CTPA can be performed at a low kV of 80 kV without loss of diagnostic quality. Unlike the increase in DNA damage as the kV value increased, the increase in oxidative stress parameters was not found to be significant. In addition, the decrease in TAS value was significant only for the 100 kV and 120 kV groups.
{"title":"Diagnostic quality, radiation exposure, and biological damage and responses following exposure at different kv values during pulmonary CT angiography.","authors":"Gürsel Çetinkaya, Mustafa Kayan, Mustafa Saygın, Ayşe Say, Gülşah Çıralı","doi":"10.1080/09553002.2025.2560856","DOIUrl":"10.1080/09553002.2025.2560856","url":null,"abstract":"<p><strong>Background: </strong>It is important to reduce the exposure to ionizing radiation, which is increasing due to medical diagnosis and treatments, and to determine the damage in the organism and the biological response to it. We aimed to investigate the radiological and biological effects of dose reduction in computed tomography pulmonary angiography (CTPA), which is increasingly used.</p><p><strong>Methods: </strong>123 patients who underwent CTPA with suspicion of pulmonary thromboembolism were divided into three groups and imaging was performed at three different kilovolt (kV) values (80, 100 and 120). Diagnostic quality, radiation exposure parameters (effective dose and dose length product [DLP]), oxidative stress parameters such as total oxidant status (TOS), malondialdehyde (MDA), oxidative stress index (OSI) and total antioxidant status (TAS) in pre- and post-scanning blood samples were evaluated. DNA was determined by comet assay.</p><p><strong>Results: </strong>No significant difference was found in terms of diagnostic quality between the three groups (p > .005). Radiation exposure parameters increased statistically significantly in line with the kV values (p < .05). The smallest increase in DNA damage after scan was detected in the group with the 80 kV(p = .001). The increase in TOS, MDA and OSI values after imaging in all three groups was not statistically significant (p > .005). The decrease in TAS values was statistically significant only in groups II and III (p < .005).</p><p><strong>Conclusion: </strong>CTPA can be performed at a low kV of 80 kV without loss of diagnostic quality. Unlike the increase in DNA damage as the kV value increased, the increase in oxidative stress parameters was not found to be significant. In addition, the decrease in TAS value was significant only for the 100 kV and 120 kV groups.</p>","PeriodicalId":94057,"journal":{"name":"International journal of radiation biology","volume":" ","pages":"1189-1195"},"PeriodicalIF":2.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145077010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: Buckwheat is a major traditional crop of hilly regions, capable of growing in adverse climatic conditions. During the survey, it was reported that prolonged consumption of buckwheat leads to digestive problems and numbness. The present study was conducted to study the effect of γ-irradiations on buckwheat to make them suitable for daily consumption.
Materials and methods: Buckwheat seeds were irradiated by 100, 200, 300, 400, 500, 600, 700, and 800 Gy doses of γ-radiations, to access the phytoconstituent variability using standard methods.
Results: Significant (p < 0.05) increase in total phenol, total flavonoid, total antioxidant activity, rutin, β-carotene, iron, calcium up to 6.23, 16.48, 18.62, 19.06, 8.08, 47.66, 32.74% in common buckwheat and 9.58, 16.66, 39.16, 9.19, 9.00, 53.99, 36.75% in tartary buckwheat was found by increasing doses of γ-radiations up to 800 Gy. Significant decrease was found in phytate, tannin, and oxalate content up to 18.92, 17.95, 15.32% in common buckwheat and 24.73, 19.72, 24.07% in tartary buckwheat.
Conclusions: It can be concluded that 800 Gy dose of γ-radiation, maximally increased the nutritional value by significant (p < 0.05) increase in nutrients and their bioavailability. This makes buckwheat more amenable for daily consumption to fulfill RDA, by Himalayan population depending on traditional foods without any digestive problem. Furthermore, significant increase in rutin by γ-radiations will be useful to fulfill the demand of cosmetic and pharmaceutical industries. But minimization of reduction loss for some nutrients by γ-radiations is the thrust area for future research.
{"title":"γ-Radiations induced phytoconstituents variability in the grains of cultivated buckwheat species of Himalayan region.","authors":"Nidhi Joshi, Kuldip Chandra Verma, Sanjay Kumar Verma, Pawanesh Tamta","doi":"10.1080/09553002.2024.2430246","DOIUrl":"10.1080/09553002.2024.2430246","url":null,"abstract":"<p><strong>Purpose: </strong>Buckwheat is a major traditional crop of hilly regions, capable of growing in adverse climatic conditions. During the survey, it was reported that prolonged consumption of buckwheat leads to digestive problems and numbness. The present study was conducted to study the effect of γ-irradiations on buckwheat to make them suitable for daily consumption.</p><p><strong>Materials and methods: </strong>Buckwheat seeds were irradiated by 100, 200, 300, 400, 500, 600, 700, and 800 Gy doses of γ-radiations, to access the phytoconstituent variability using standard methods.</p><p><strong>Results: </strong>Significant (<i>p</i> < 0.05) increase in total phenol, total flavonoid, total antioxidant activity, rutin, β-carotene, iron, calcium up to 6.23, 16.48, 18.62, 19.06, 8.08, 47.66, 32.74% in common buckwheat and 9.58, 16.66, 39.16, 9.19, 9.00, 53.99, 36.75% in tartary buckwheat was found by increasing doses of γ-radiations up to 800 Gy. Significant decrease was found in phytate, tannin, and oxalate content up to 18.92, 17.95, 15.32% in common buckwheat and 24.73, 19.72, 24.07% in tartary buckwheat.</p><p><strong>Conclusions: </strong>It can be concluded that 800 Gy dose of γ-radiation, maximally increased the nutritional value by significant (<i>p</i> < 0.05) increase in nutrients and their bioavailability. This makes buckwheat more amenable for daily consumption to fulfill RDA, by Himalayan population depending on traditional foods without any digestive problem. Furthermore, significant increase in rutin by γ-radiations will be useful to fulfill the demand of cosmetic and pharmaceutical industries. But minimization of reduction loss for some nutrients by γ-radiations is the thrust area for future research.</p>","PeriodicalId":94057,"journal":{"name":"International journal of radiation biology","volume":" ","pages":"73-84"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142676879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-01-27DOI: 10.1080/09553002.2025.2451630
Mohammad Mahbubul Haque, Gobinda Chandra Das, Md Mostofa Faysal, Muhammed Ali Hossain, Marjana Haque, Sifat Miah, Jannatul Farthouse, Mashukur Rahman, Md Nazmul Hasan Mehedi
Purpose: The study focused on developing a rapid PCR-based detection method and employing gamma irradiation techniques to manage Ralstonia solanacearum, aiming to produce brown rot-free export-quality potatoes. This initiative seeks to enhance potato exports from Bangladesh.
Materials and methods: Samples of potato tubers and soil were collected from various commercially significant potato-growing areas, resulting in a total of 168 Ralstonia solanacearum isolates from potato tubers and soil across 12 regions. The detection of R. solanacearum in the enriched tuber extract and soil were conducted using the primer pairs (PS-1, PS-2) and (759, 760). For the gamma irradiation experiment, petri dishes containing R. solanacearum cultures were subjected to different doses of gamma rays at the Bangladesh Institute of Nuclear Agriculture using a 60Co source. The irradiation doses applied to the samples were 0-6.0KGy.
Results: Morphological identification based on pink/light red colonies on TTC medium was confirmed R. solanacearum in 148 isolates. PCR using species-specific primers (PS-1/PS-2) and (759, 760) verified 26 isolates (14 tubers, 12 soil), producing 553 bp and 281 bp fragments in latently infected tubers and soil samples respectively. Gamma irradiation at 2.5 kGy damaged R. solanacearum's DNA and cells, preventing brown rot, while higher doses eliminated it entirely. This offers a promising strategy to enhance safety of stored potatoes, potentially mitigating economic losses from this quarantine pathogen.
Conclusion: The study developed a PCR detection method and gamma irradiation techniques to manage R. solanacearum, enhancing the export quality of potatoes.
{"title":"PCR-based detection technique and gamma irradiation strategies for managing <i>Ralstonia solanacearum</i>-induced brown rot of potato.","authors":"Mohammad Mahbubul Haque, Gobinda Chandra Das, Md Mostofa Faysal, Muhammed Ali Hossain, Marjana Haque, Sifat Miah, Jannatul Farthouse, Mashukur Rahman, Md Nazmul Hasan Mehedi","doi":"10.1080/09553002.2025.2451630","DOIUrl":"10.1080/09553002.2025.2451630","url":null,"abstract":"<p><strong>Purpose: </strong>The study focused on developing a rapid PCR-based detection method and employing gamma irradiation techniques to manage <i>Ralstonia solanacearum</i>, aiming to produce brown rot-free export-quality potatoes. This initiative seeks to enhance potato exports from Bangladesh.</p><p><strong>Materials and methods: </strong>Samples of potato tubers and soil were collected from various commercially significant potato-growing areas, resulting in a total of 168 <i>Ralstonia solanacearum</i> isolates from potato tubers and soil across 12 regions. The detection of <i>R. solanacearum</i> in the enriched tuber extract and soil were conducted using the primer pairs (PS-1, PS-2) and (759, 760). For the gamma irradiation experiment, petri dishes containing <i>R. solanacearum</i> cultures were subjected to different doses of gamma rays at the Bangladesh Institute of Nuclear Agriculture using a <sup>60</sup>Co source. The irradiation doses applied to the samples were 0-6.0KGy.</p><p><strong>Results: </strong>Morphological identification based on pink/light red colonies on TTC medium was confirmed <i>R. solanacearum</i> in 148 isolates. PCR using species-specific primers (PS-1/PS-2) and (759, 760) verified 26 isolates (14 tubers, 12 soil), producing 553 bp and 281 bp fragments in latently infected tubers and soil samples respectively. Gamma irradiation at 2.5 kGy damaged <i>R. solanacearum's</i> DNA and cells, preventing brown rot, while higher doses eliminated it entirely. This offers a promising strategy to enhance safety of stored potatoes, potentially mitigating economic losses from this quarantine pathogen.</p><p><strong>Conclusion: </strong>The study developed a PCR detection method and gamma irradiation techniques to manage <i>R. solanacearum</i>, enhancing the export quality of potatoes.</p>","PeriodicalId":94057,"journal":{"name":"International journal of radiation biology","volume":" ","pages":"382-390"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143049363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-03-04DOI: 10.1080/09553002.2025.2470202
Miriam Tomaciello, Antonio Sciurti, Luisa Caprara, Miriam Conte, Viviana Frantellizzi, Giuseppe De Vincentis, Lucy Zaccaro, Giorgia Cunicella, Alberto Fallico, Carlo Guglielmo Cattaneo, Roberto Lisi, Silvia Arcieri, Carlina Veneranda Albanese, Paolo Tini, Beatrice Detti, Vanessa Di Cataldo, Monica Mangoni, Giulio Francolini, Giuseppe Migliara, Lorenzo Livi, Francesca De Felice, Giuseppe Minniti, Giovanni Luca Gravina, Valentina Baccolini, Francesco Marampon
Purpose: To investigate the effects of radical radiotherapy (RT) relevant interruptions (RRI), single (sRRI) or multiple (mRRI), on Biochemical Failure-Free Survival (BFFS), Metastases-Free Survival (MFS) and Overall Survival (OS) in prostate cancer (PCa) patients.
Methods: We conducted a retrospective analysis involving 383 patients diagnosed with prostate cancer (PCa) who received radical RT between March 2013 and April 2021, with doses ranging from 60 to 80 Gy (median dose 76.0 Gy), either alone or in combination with androgen deprivation therapy. The study aimed to evaluate the effects of sRRI and mRRI radiation-related interruptions on BFFS, MFS, and OS using the Kaplan-Meier method. Additionally, we adjusted for relevant prognostic factors using three multivariate Cox regression proportional hazard models.
Results: In the univariate analysis, it was observed that patients who experienced unexpected RRIs (50.1%: 35.5% sRRI and 14.6% mRRI), resulting in a median overall treatment time prolongation of five days, exhibited a higher incidence of biochemical failure (BF) and metastases (Met). However, no difference was observed in OS. In the multivariate analysis, it was found that RRIs were significantly associated with increased hazards of BF (sRRI, aHR: 4.61, 95% CI: 2.80-7.60; mRRIs, aHR: 9.92, 95% CI: 5.61-17.54), Met (sRRI, aHR: 4.20, 95% CI: 1.97-8.94; mRRI, aHR: 7.01, 95% CI: 2.94-6.71), and all-cause mortality (mRRI, aHR: 1.89, 95% CI: 1.18-3.03).
Conclusions: sRRIs were associated with both lower BFFS and MFS, while mRRIs with both BFFS, MFS and OS.
{"title":"Significant interruptions in radiotherapy during curative treatment for prostate cancer are correlated with poorer oncological outcomes.","authors":"Miriam Tomaciello, Antonio Sciurti, Luisa Caprara, Miriam Conte, Viviana Frantellizzi, Giuseppe De Vincentis, Lucy Zaccaro, Giorgia Cunicella, Alberto Fallico, Carlo Guglielmo Cattaneo, Roberto Lisi, Silvia Arcieri, Carlina Veneranda Albanese, Paolo Tini, Beatrice Detti, Vanessa Di Cataldo, Monica Mangoni, Giulio Francolini, Giuseppe Migliara, Lorenzo Livi, Francesca De Felice, Giuseppe Minniti, Giovanni Luca Gravina, Valentina Baccolini, Francesco Marampon","doi":"10.1080/09553002.2025.2470202","DOIUrl":"10.1080/09553002.2025.2470202","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the effects of radical radiotherapy (RT) relevant interruptions (RRI), single (sRRI) or multiple (mRRI), on Biochemical Failure-Free Survival (BFFS), Metastases-Free Survival (MFS) and Overall Survival (OS) in prostate cancer (PCa) patients.</p><p><strong>Methods: </strong>We conducted a retrospective analysis involving 383 patients diagnosed with prostate cancer (PCa) who received radical RT between March 2013 and April 2021, with doses ranging from 60 to 80 Gy (median dose 76.0 Gy), either alone or in combination with androgen deprivation therapy. The study aimed to evaluate the effects of sRRI and mRRI radiation-related interruptions on BFFS, MFS, and OS using the Kaplan-Meier method. Additionally, we adjusted for relevant prognostic factors using three multivariate Cox regression proportional hazard models.</p><p><strong>Results: </strong>In the univariate analysis, it was observed that patients who experienced unexpected RRIs (50.1%: 35.5% sRRI and 14.6% mRRI), resulting in a median overall treatment time prolongation of five days, exhibited a higher incidence of biochemical failure (BF) and metastases (Met). However, no difference was observed in OS. In the multivariate analysis, it was found that RRIs were significantly associated with increased hazards of BF (sRRI, aHR: 4.61, 95% CI: 2.80-7.60; mRRIs, aHR: 9.92, 95% CI: 5.61-17.54), Met (sRRI, aHR: 4.20, 95% CI: 1.97-8.94; mRRI, aHR: 7.01, 95% CI: 2.94-6.71), and all-cause mortality (mRRI, aHR: 1.89, 95% CI: 1.18-3.03).</p><p><strong>Conclusions: </strong>sRRIs were associated with both lower BFFS and MFS, while mRRIs with both BFFS, MFS and OS.</p>","PeriodicalId":94057,"journal":{"name":"International journal of radiation biology","volume":" ","pages":"467-474"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143560471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-01-10DOI: 10.1080/09553002.2024.2447509
Jae Yun Moon, Jae Berm Park, Kyo Won Lee, Daechan Park, Gyu Sang Yoo, Changhoon Choi, Sohee Park, Jeong Il Yu, Do Hoon Lim, Jung Eun Kim, Sung Joo Kim, Woo-Yoon Park, Won Dong Kim
Purpose: We aimed to identify the transcriptomic signatures of soft tissue sarcoma (STS) related to radioresistance and establish a model to predict radioresistance.
Materials and methods: Nine STS cell lines were cultured. Adenosine triphosphate-based viability was determined 5 days after irradiation with 8 Gy of X-rays in a single fraction. Radiosensitive and radioresistant groups were stratified according to the survival rates. Whole transcriptomic sequencing analysis was performed and differentially expressed genes (DEGs) were identified between the radiosensitive and radioresistant groups. For model generation, a cohort of 59 patients with sarcomas from The Cancer Genome Atlas (TCGA) was used. DEGs of the responder and non-responder groups according to the radiotherapy-best response were identified. The overlapping DEGs between those from TCGA data and the STS cell line were subjected to linear regression to develop a formula, namely the STS-specific radioresistance index (STS-RRI), and its performance was compared with that of the previously established radiosensitivity index (RSI).
Results: We selected thirteen overlapping DEGs and established STS-RRI using seven of them: STS-RRI = 1.5185 × MYO16-0.01575 × MYH11 + 3.900375 × KCTD16 + 0.105375 × SYNPO2-0.777375 × MYPN-0.849875 × PCSK6-0.700125 × LTK + 39.4635. Delong's test revealed that the STS-RRI performed better at stratifying responder and non-responder in TCGA cohort than the RSI (p = .002). The progression-free survival curves of the TCGA cohort were significantly discriminated by STS-RRI (p = .013) but not by RSI (p = .241).
Conclusion: We developed the STS-RRI to predict the radioresistance of patients with STS in the TCGA dataset, showing a higher performance than RSI.
{"title":"Identification and validation of soft tissue sarcoma-specific transcriptomic model for predicting radioresistance.","authors":"Jae Yun Moon, Jae Berm Park, Kyo Won Lee, Daechan Park, Gyu Sang Yoo, Changhoon Choi, Sohee Park, Jeong Il Yu, Do Hoon Lim, Jung Eun Kim, Sung Joo Kim, Woo-Yoon Park, Won Dong Kim","doi":"10.1080/09553002.2024.2447509","DOIUrl":"10.1080/09553002.2024.2447509","url":null,"abstract":"<p><strong>Purpose: </strong>We aimed to identify the transcriptomic signatures of soft tissue sarcoma (STS) related to radioresistance and establish a model to predict radioresistance.</p><p><strong>Materials and methods: </strong>Nine STS cell lines were cultured. Adenosine triphosphate-based viability was determined 5 days after irradiation with 8 Gy of X-rays in a single fraction. Radiosensitive and radioresistant groups were stratified according to the survival rates. Whole transcriptomic sequencing analysis was performed and differentially expressed genes (DEGs) were identified between the radiosensitive and radioresistant groups. For model generation, a cohort of 59 patients with sarcomas from The Cancer Genome Atlas (TCGA) was used. DEGs of the responder and non-responder groups according to the radiotherapy-best response were identified. The overlapping DEGs between those from TCGA data and the STS cell line were subjected to linear regression to develop a formula, namely the STS-specific radioresistance index (STS-RRI), and its performance was compared with that of the previously established radiosensitivity index (RSI).</p><p><strong>Results: </strong>We selected thirteen overlapping DEGs and established STS-RRI using seven of them: STS-RRI = 1.5185 × MYO16-0.01575 × MYH11 + 3.900375 × KCTD16 + 0.105375 × SYNPO2-0.777375 × MYPN-0.849875 × PCSK6-0.700125 × LTK + 39.4635. Delong's test revealed that the STS-RRI performed better at stratifying responder and non-responder in TCGA cohort than the RSI (<i>p</i> = .002). The progression-free survival curves of the TCGA cohort were significantly discriminated by STS-RRI (<i>p</i> = .013) but not by RSI (<i>p</i> = .241).</p><p><strong>Conclusion: </strong>We developed the STS-RRI to predict the radioresistance of patients with STS in the TCGA dataset, showing a higher performance than RSI.</p>","PeriodicalId":94057,"journal":{"name":"International journal of radiation biology","volume":" ","pages":"283-291"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142962524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-02-13DOI: 10.1080/09553002.2025.2449953
Mehmet Gurbilek, Cigdem D Deniz, Canan Eroglu Gunes, Ercan Kurar, Ismail Reisli, Muammer A Kursunel, Cemile Topcu, Mehmet Koc
Purpose: Thymoquinone (TQ) is an ingredient of Nigella sativa and Cisplatin (CDDP) is the most active chemotherapeutic agent in lung cancer. The objective of this study was to assess the anticancer effects of TQ in non-small cell lung cancer (NSCLC) cells, and its effect on the peroxisome proliferator-activated receptor gamma (PPAR-γ) pathway.
Methods: Annexin-V FITC assay was used in the NCI-H460 cell line for apoptosis. The mRNA expression of PPAR-γ, P53, BCL-2, Retinoblastoma (Rb), Cyclin-D1, RELA, Tumor necrosis Factor alpha and in a dose-dependent manner TQ activated caspases 9, 8, 7, and 3 were examined using quantitative real-time reverse transcriptase polymerase chain reaction.
Results: PPAR-γ protein levels elevated in all treatment groups, especially in the CDDP + TQ group as observed in mRNA results. In the CDDP + TQ + IR group, the reduction of NF-κB pathway, which provides survival and growth signaling, confirms the potential of this treatment in lung cancer treatment approach similar to p53, Rb, and PPAR-γ results. When the effect of treatment on the viability of NSCLC cells was assessed with flow cytometry analyzes, TQ alone supported death compared to control, cell viability also decreased in the CDDP or IR groups to which TQ was added.
Conclusion: As a result, combined therapy of TQ, CDDP, and IR have been shown to increase apoptosis by sensitizing NSCLC cells to IR. These in vitro results are the basis because they demonstrate that it may be useful to include TQ in combined NSCLC cell treatments to reduce tumor progression.
{"title":"Anticancer activity of thymoquinone in non-small cell lung cancer and possible involvement of PPAR-<i>γ</i> pathway.","authors":"Mehmet Gurbilek, Cigdem D Deniz, Canan Eroglu Gunes, Ercan Kurar, Ismail Reisli, Muammer A Kursunel, Cemile Topcu, Mehmet Koc","doi":"10.1080/09553002.2025.2449953","DOIUrl":"10.1080/09553002.2025.2449953","url":null,"abstract":"<p><strong>Purpose: </strong>Thymoquinone (TQ) is an ingredient of <i>Nigella sativa</i> and Cisplatin (CDDP) is the most active chemotherapeutic agent in lung cancer. The objective of this study was to assess the anticancer effects of TQ in non-small cell lung cancer (NSCLC) cells, and its effect on the peroxisome proliferator-activated receptor gamma (PPAR-<i>γ</i>) pathway.</p><p><strong>Methods: </strong>Annexin-V FITC assay was used in the NCI-H460 cell line for apoptosis. The mRNA expression of PPAR-<i>γ</i>, P53, BCL-2, Retinoblastoma (Rb), Cyclin-D1, RELA, Tumor necrosis Factor alpha and in a dose-dependent manner TQ activated caspases 9, 8, 7, and 3 were examined using quantitative real-time reverse transcriptase polymerase chain reaction.</p><p><strong>Results: </strong>PPAR-<i>γ</i> protein levels elevated in all treatment groups, especially in the CDDP + TQ group as observed in mRNA results. In the CDDP + TQ + IR group, the reduction of NF-κB pathway, which provides survival and growth signaling, confirms the potential of this treatment in lung cancer treatment approach similar to p53, Rb, and PPAR-<i>γ</i> results. When the effect of treatment on the viability of NSCLC cells was assessed with flow cytometry analyzes, TQ alone supported death compared to control, cell viability also decreased in the CDDP or IR groups to which TQ was added.</p><p><strong>Conclusion: </strong>As a result, combined therapy of TQ, CDDP, and IR have been shown to increase apoptosis by sensitizing NSCLC cells to IR. These in vitro results are the basis because they demonstrate that it may be useful to include TQ in combined NSCLC cell treatments to reduce tumor progression.</p>","PeriodicalId":94057,"journal":{"name":"International journal of radiation biology","volume":" ","pages":"370-381"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143416388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}